Novo Nordisk is a global healthcare company that specializes in pharmaceutical products. It has two main segments, Diabetes and Obesity care, and Biopharm, which provide products for various chronic diseases, including insulins, oral antidiabetic products, obesity, and hormone replacement therapy. The company collaborates with other pharmaceutical companies and has a research collaboration with Lumen Bioscience, Inc. to explore new strategies for delivering oral biologics for cardiometabolic disease.